Looking to Start Your PCD Pharma Franchise? Join Hands with Vision Plus Healthcare.
Join a network of WHO-GMP certified pharmaceutical leaders. Secure monopoly rights in your territory today with high-quality medicine ranges.
Discover why thousands of entrepreneurs are choosing the PCD model for sustainable business growth.
Start your own business with minimal capital investment. The PCD model reduces financial risks while offering high returns on investment.
The Indian pharmaceutical market is expanding at an unprecedented rate, providing a fertile ground for new franchise partners to thrive.
Leverage Vision Plus Healthcare's reputation and WHO-GMP certifications to gain instant trust from healthcare professionals.
A transparent look at our collaborative ecosystem..
Vision Plus handles high-quality manufacturing, R&D, and bulk supply.
You manage distribution, stock-keeping, and local marketing in your territory.
Doctors and clinics prescribe our certified products based on quality trust.
Patients receive affordable, effective, and reliable medical treatment.
As a premier PCD provider in India, we understand the local dynamics and provide tools specifically designed for your regional success
Zero competition in your allocated district or region.
Visual aids, catch covers, and MR bags provided.
Access 500+ products across all therapeutic segments.
Robust logistics network ensuring stock reaches you within 48-72 hours.
A streamlined 4-step process to becoming a Vision Plus distributor.
Fill out our franchise application form with your details and target territory.
Our team reviews your credentials and checks territory exclusivity status.
Choose from our wide range of therapeutic segments and product categories.
Receive your stock and marketing material to start operations immediately.
Our state-of-the-art manufacturing facilities are equipped with the latest technology to ensure international quality standards. We maintain strict quality control at every stage of production.
VisionPlus Healthcare PCD Pharma Franchise
